한글목차

바이오스락스 시장 규모는 최근 몇 년간 크게 성장했습니다. 2025년 93만 달러에서 2026년에는 101만 달러에 이르고, CAGR 8.8%의 성장이 전망되고 있습니다. 지난 몇 년간의 성장에는 생물테러 위협에 대한 인식, 정부 지원 백신 프로그램, 군 예방접종 요건, 과거 탄저균 노출 사례, 집중적인 예방접종 캠페인에 대한 의존도 등이 영향을 미친 것으로 추정됩니다.

바이오스락스 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 2030년에는 140만 달러에 이르고, CAGR은 8.5%를 나타낼 전망입니다. 예측 기간의 성장 요인으로는 국토 안보 투자 증가, 세계 생물방어 협력 확대, 비상 대응 정책 확대, 동물용 탄저병 예방 프로그램 성장, 백신 보관 인프라 현대화 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 생물방어 준비에 대한 관심 증가, 정부 비축 프로그램 확대, 노출 전 예방접종(PEP) 활용 증가, 비상대응 준비태세 강화, 국가 예방접종 보안 프로그램 강화 등을 꼽을 수 있습니다.

향후 바이오트랙스 시장의 성장을 견인할 것으로 예상되는 것은 육류 소비 증가입니다. 육류 소비는 급속한 도시화, 소득수준 증가, 식습관의 변화, 육류를 주요 단백질 및 영양 공급원으로 여기는 문화적 취향 등의 요인에 영향을 받고 있습니다. 바이오트랙스는 가축의 탄저병 예방접종에 사용되며, 오염된 고기를 통해 전염될 수 있는 이 질병으로부터 가축을 보호함으로써 육류 안전성 확보와 인수공통전염병 발생으로 인한 공중보건 보호에 기여합니다. 예를 들어, 유엔식량농업기구(FAO)에 따르면 2023년 6월 기준 세계 육류 생산량은 2023년 3억 6,390만 톤에 달할 전망입니다. 이처럼 육류 소비 증가는 바이오트럭 시장의 성장에 기여하고 있습니다.

또한, 탄저균의 확산 확대도 향후 바이오트랙스 시장의 성장을 가속할 것으로 예측됩니다. 탄저균의 확산은 주로 토양에 지속적으로 존재하는 탄저균(Bacillus anthracis) 포자에 의해 발생하며, 접촉이나 섭취를 통해 동물이나 사람에게 감염됩니다. 바이오트랙스는 면역체계를 자극해 탄저균에 대한 항체를 생산하게 함으로써 감염 위험을 줄이고 탄저병을 예방하는 백신입니다. 예를 들어, 세계보건기구(WHO)에 따르면 2023년 12월 현재 잠비아는 2023년 11월까지 684건의 인간 탄저균 감염 의심 사례를 보고했으며, 이 중 4명이 사망해 치사율은 0.6%에 해당합니다. 이처럼 탄저균 감염증 증가 추세가 바이오트럭 시장의 성장을 견인하고 있는 것입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 한국 시장

제17장 서유럽 시장

제18장 영국 시장

제19장 독일 시장

제20장 프랑스 시장

제21장 동유럽 시장

제22장 북미 시장

제23장 미국 시장

제24장 캐나다 시장

제25장 남미 시장

제26장 중동 시장

제27장 아프리카 시장

제28장 시장 규제 상황과 투자환경

제29장 경쟁 구도와 기업 개요

제30장 세계 시장 경쟁 벤치마킹과 대시보드

제31장 주요 인수합병(M&A)

제32장 시장 잠재력이 높은 국가, 부문, 전략

제33장 부록

영문목차

Biothrax is a vaccine developed to protect against anthrax, a serious and potentially life-threatening disease caused by the bacterium Bacillus anthracis. The vaccine functions by stimulating the immune system to generate antibodies against anthrax toxins, which can be fatal if exposure occurs, particularly in bioterrorism-related situations.

The main types in the Biothrax market include live vaccines and cell-free protective antigen vaccines. Live vaccines are produced from weakened, or attenuated, organisms that do not cause disease but effectively trigger a strong immune response. The clinical indications include pre-exposure prophylaxis and post-exposure prophylaxis. The vaccine is used for both human and animal applications, and the end users include hospitals, clinics, vaccination centers, and other healthcare facilities.

Tariffs have influenced the biothrax market by increasing costs associated with imported vaccine ingredients, sterile vials, and cold-chain logistics equipment. These impacts have affected government procurement budgets, particularly in regions that rely on cross-border sourcing for biodefense vaccines. Hospital and vaccination center segments in regions such as asia-pacific and middle east are more sensitive to tariff-driven cost fluctuations. At the same time, tariffs have encouraged domestic vaccine manufacturing, strengthened national stockpiling capabilities, and improved long-term biodefense supply security.

The biothrax market research report is one of a series of new reports from The Business Research Company that provides biothrax market statistics, including biothrax industry global market size, regional shares, competitors with a biothrax market share, detailed biothrax market segments, market trends and opportunities, and any further data you may need to thrive in the biothrax industry. This biothrax market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biothrax market size has grown strongly in recent years. It will grow from $0.93 million in 2025 to $1.01 million in 2026 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to bioterrorism threat awareness, government-funded vaccine programs, military immunization requirements, historical anthrax exposure incidents, reliance on centralized vaccination campaigns.

The biothrax market size is expected to see strong growth in the next few years. It will grow to $1.4 million in 2030 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to increased homeland security investments, rising global biodefense collaborations, expansion of emergency preparedness policies, growth in animal anthrax prevention programs, modernization of vaccine storage infrastructure. Major trends in the forecast period include rising focus on biodefense preparedness, expansion of government stockpiling programs, increased use of pre-exposure prophylaxis vaccination, growing emphasis on emergency response readiness, strengthening of national immunization security programs.

The increasing consumption of meat is expected to drive the growth of the BioThrax market going forward. Meat consumption is influenced by factors such as rapid urbanization, rising income levels, changing dietary habits, and cultural preferences that emphasize meat as a major source of protein and nutrition. BioThrax is used to vaccinate livestock against anthrax, a disease that can be transmitted through contaminated meat, thereby helping ensure meat safety and protecting public health from zoonotic disease outbreaks. For instance, in June 2023, according to the Food and Agriculture Organization of the United Nations, global meat production increased to 363.9 million metric tons in 2023. Thus, the rising consumption of meat is contributing to the growth of the BioThrax market.

The growing prevalence of anthrax is also expected to propel the growth of the BioThrax market going forward. Anthrax prevalence is largely driven by the persistence of Bacillus anthracis spores in soil, which can infect animals and humans through contact or ingestion. BioThrax is a vaccine that helps prevent anthrax by stimulating the immune system to produce antibodies against Bacillus anthracis, thereby reducing the risk of infection. For instance, in December 2023, according to the World Health Organization, Zambia reported 684 suspected human anthrax cases as of November 2023, including four deaths, corresponding to a case fatality ratio of 0.6%. Thus, the increasing prevalence of anthrax is driving the growth of the BioThrax market.

Major companies operating in the BioThrax market are concentrating on strategic investments to strengthen production capacity, expand their geographic reach, and develop advanced anthrax vaccines. Strategic funding supports clinical trials and helps meet regulatory requirements, enabling companies to secure approvals across multiple countries. This, in turn, improves the availability of vaccines in underserved regions. For instance, in January 2024, Emergent BioSolutions, a US-based biotechnology company, received a major contract valued at up to $235.8 million from the U.S. Department of Defense (DoD) to supply BioThrax (Anthrax Vaccine Adsorbed) for military use. This contract highlights the continued demand for effective anthrax vaccines within the U.S. military and demonstrates Emergent's long-standing partnership with government agencies in delivering biodefense solutions.

Major companies operating in the biothrax market are Emergent Bio-Solutions

North America was the largest region in the biothrax market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biothrax market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the biothrax market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

The biothrax market consists of sales of single-dose vials and multi-dose vials. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biothrax Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses biothrax market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biothrax ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biothrax market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Live Vaccines; Cell Free Protective Antigen Vaccines
• 2) By Clinical Indication: Pre-Exposure Prophylaxis; Post-Exposure Prophylaxis
• 3) By Application: Human Use; Animal Use
• 4) By End-User: Hospital; Clinics; Vaccination Centers; Other End-Users
• Companies Mentioned: Emergent Bio-Solutions
• Countries: Australia; India; China; South Korea; Japan; UK; France; Germany; USA; Canada.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Biothrax Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Biothrax Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Biothrax Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Biothrax Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Sustainability, Climate Tech & Circular Economy
• 4.2. Major Trends
  • 4.2.1 Rising Focus On Biodefense Preparedness
  • 4.2.2 Expansion Of Government Stockpiling Programs
  • 4.2.3 Increased Use Of Pre-Exposure Prophylaxis Vaccination
  • 4.2.4 Growing Emphasis On Emergency Response Readiness
  • 4.2.5 Strengthening Of National Immunization Security Programs

5. Biothrax Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Clinics
• 5.3 Vaccination Centers
• 5.4 Military Healthcare Facilities
• 5.5 Public Health Agencies

6. Biothrax Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Biothrax Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Biothrax PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Biothrax Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Biothrax Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Biothrax Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Biothrax Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Biothrax Market Segmentation

• 9.1. Global Biothrax Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Live Vaccines, Cell Free Protective Antigen Vaccines
• 9.2. Global Biothrax Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Pre-Exposure Prophylaxis, Post-Exposure Prophylaxis
• 9.3. Global Biothrax Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Human Use, Animal Use
• 9.4. Global Biothrax Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospital, Clinics, Vaccination Centers, Other End-Users

10. Biothrax Market Regional And Country Analysis

• 10.1. Global Biothrax Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Biothrax Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Biothrax Market

• 11.1. Asia-Pacific Biothrax Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Biothrax Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Biothrax Market

• 12.1. China Biothrax Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Biothrax Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Biothrax Market

• 13.1. India Biothrax Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Biothrax Market

• 14.1. Japan Biothrax Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Biothrax Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Biothrax Market

• 15.1. Australia Biothrax Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. South Korea Biothrax Market

• 16.1. South Korea Biothrax Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 16.2. South Korea Biothrax Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Western Europe Biothrax Market

• 17.1. Western Europe Biothrax Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. Western Europe Biothrax Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. UK Biothrax Market

• 18.1. UK Biothrax Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Germany Biothrax Market

• 19.1. Germany Biothrax Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. France Biothrax Market

• 20.1. France Biothrax Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Eastern Europe Biothrax Market

• 21.1. Eastern Europe Biothrax Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 21.2. Eastern Europe Biothrax Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. North America Biothrax Market

• 22.1. North America Biothrax Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 22.2. North America Biothrax Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. USA Biothrax Market

• 23.1. USA Biothrax Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 23.2. USA Biothrax Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Canada Biothrax Market

• 24.1. Canada Biothrax Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 24.2. Canada Biothrax Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. South America Biothrax Market

• 25.1. South America Biothrax Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 25.2. South America Biothrax Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Middle East Biothrax Market

• 26.1. Middle East Biothrax Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Middle East Biothrax Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Africa Biothrax Market

• 27.1. Africa Biothrax Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 27.2. Africa Biothrax Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Biothrax Market Regulatory and Investment Landscape

29. Biothrax Market Competitive Landscape And Company Profiles

• 29.1. Biothrax Market Competitive Landscape And Market Share 2024
  • 29.1.1. Top 10 Companies (Ranked by revenue/share)
• 29.2. Biothrax Market - Company Scoring Matrix
  • 29.2.1. Market Revenues
  • 29.2.2. Product Innovation Score
  • 29.2.3. Brand Recognition
• 29.3. Biothrax Market Company Profiles
  • 29.3.1. Emergent Bio-Solutions Overview, Products and Services, Strategy and Financial Analysis

30. Global Biothrax Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Biothrax Market

32. Biothrax Market High Potential Countries, Segments and Strategies

• 32.1 Biothrax Market In 2030 - Countries Offering Most New Opportunities
• 32.2 Biothrax Market In 2030 - Segments Offering Most New Opportunities
• 32.3 Biothrax Market In 2030 - Growth Strategies
  • 32.3.1 Market Trend Based Strategies
  • 32.3.2 Competitor Strategies

33. Appendix

• 33.1. Abbreviations
• 33.2. Currencies
• 33.3. Historic And Forecast Inflation Rates
• 33.4. Research Inquiries
• 33.5. The Business Research Company
• 33.6. Copyright And Disclaimer